The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study

J Thromb Haemost. 2011 Jan;9(1):226-8. doi: 10.1111/j.1538-7836.2010.04106.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Blood Coagulation / drug effects*
  • Calibration
  • Drug Monitoring / methods*
  • Factor Xa Inhibitors
  • Feasibility Studies
  • Fibrinolytic Agents / blood
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Morpholines / blood
  • Morpholines / pharmacology*
  • Prothrombin Time / standards*
  • Reference Standards
  • Rivaroxaban
  • Tetrazolium Salts / standards*
  • Thiophenes / blood
  • Thiophenes / pharmacology*
  • Thromboplastin

Substances

  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Morpholines
  • Tetrazolium Salts
  • Thiophenes
  • iodonitrotetrazolium
  • Thromboplastin
  • Rivaroxaban